Relevant to these observations, histological analyses have shown that β-cells of new onset T1D patients express CXCL10, while the islet-infiltrating lymphocytes express its receptor (CXCR3) [73]. This evidence concerns the gene CXCL10 and type 1 diabetes mellitus.